Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes

Cell Metabolism

Volumn 1, Issue 2, 2005, Pages 107-119

  Maeda, Kazuhisa ^a   Cao, Haiming ^a   Kono, Keita ^a   Gorgun, Cem Z ^a   Furuhashi, Masato ^a   Uysal, Kadir T ^a   Cao, Qiong ^a   Atsumi, Genichi ^a   Malone, Harry ^c   Krishnan, Bala ^c   Minokoshi, Yasuhiko ^b   Kahn, Barbara B ^b   Parker, Rex A ^c   Hotamisligil, Gökhan S ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; FATTY ACID BINDING PROTEIN; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INSULIN RECEPTOR; LIPID; 5' AMP ACTIVATED PROTEIN KINASE; 5'-AMP-ACTIVATED PROTEIN KINASE; ACYL COENZYME A DESATURASE; CARRIER PROTEIN; CYTOKINE; FATTY ACID; MESSENGER RNA; MULTIENZYME COMPLEX; OXYGEN; PROTEIN SERINE THREONINE KINASE; SCD1 PROTEIN, MOUSE; TRIACYLGLYCEROL;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; FATTY LIVER; GLUCOSE METABOLISM; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; LIPID TRANSPORT; MACROPHAGE; MALE; METABOLIC SYNDROME X; MOUSE; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ADIPOSE TISSUE; ANIMAL; ARTERIOSCLEROSIS; BODY WEIGHT; C57BL MOUSE; CYTOLOGY; DIABETES MELLITUS; GENE EXPRESSION REGULATION; IMMUNOBLOTTING; LIVER; METABOLISM; PHOSPHORYLATION; TIME; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; ARTERIOSCLEROSIS; BODY WEIGHT; CARRIER PROTEINS; CYTOKINES; DIABETES MELLITUS; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; GENE EXPRESSION REGULATION; GLUCOSE; IMMUNOBLOTTING; INFLAMMATION; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MULTIENZYME COMPLEXES; MUTATION; OBESITY; OXYGEN; PHENOTYPE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, INSULIN; RNA, MESSENGER; STEAROYL-COA DESATURASE; TIME FACTORS; TISSUE DISTRIBUTION; TRIGLYCERIDES;

EID: 18244363982     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2004.12.008     Document Type: Article

References (41)

1. Abel E.D., Peroni O., Kim J.K., Kim Y.B., Boss O., Hadro E., Minnemann T., Shulman G.I., and Kahn B.B. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409 (2001) 729-733
2. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257 (1999) 79-83
3. Bernlohr D.A., Coe N.R., and LiCata V.J. Fatty acid trafficking in the adipocyte. Semin. Cell Dev. Biol. 10 (1999) 43-49
4. Boord J.B., Maeda K., Makowski L., Babaev V.R., Fazio S., Linton M.F., and Hotamisligil G.S. Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 1686-1691
5. Boord J.B., Maeda K., Makowski L., Babaev V.R., Fazio S., Linton M.F., and Hotamisligil G.S. Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice. Circulation 110 (2004) 1492-1498
6. Bruning J.C., Michael M.D., Winnay J.N., Hayashi T., Horsch D., Accili D., Goodyear L.J., and Kahn C.R. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2 (1998) 559-569
7. Chavez J.A., and Summers S.A. Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch. Biochem. Biophys. 419 (2003) 101-109
8. Cohen P., Miyazaki M., Socci N.D., Hagge-Greenberg A., Liedtke W., Soukas A.A., Sharma R., Hudgins L.C., Ntambi J.M., and Friedman J.M. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 297 (2002) 240-243
9. Dole V.P., and Meinertz H. Microdetermination of long-chain fatty acids in plasma and tissues. J. Biol. Chem. 235 (1960) 2595-2599
10. Flegal K.M., Carroll M.D., Kuczmarski R.J., and Johnson C.L. Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int. J. Obes. Relat. Metab. Disord. 22 (1998) 39-47
11. Friedman J.M., and Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 395 (1998) 763-770
12. Fruebis J., Tsao T.S., Javorschi S., Ebbets-Reed D., Erickson M.R., Yen F.T., Bihain B.E., and Lodish H.F. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. USA 98 (2001) 2005-2010
13. Glatz J.F., and Veerkamp J.H. A radiochemical procedure for the assay of fatty acid binding by proteins. Anal. Biochem. 132 (1983) 89-95
14. Gomez F.E., Miyazaki M., Kim Y.C., Marwah P., Lardy H.A., Ntambi J.M., and Fox B.G. Molecular differences caused by differentiation of 3T3-L1 preadipocytes in the presence of either dehydroepiandrosterone (DHEA) or 7-oxo-DHEA. Biochemistry 41 (2002) 5473-5482
15. Hirosumi J., Tuncman G., Chang L., Gorgun C.Z., Uysal K.T., Maeda K., Karin M., and Hotamisligil G.S. A central role for JNK in obesity and insulin resistance. Nature 420 (2002) 333-336
16. Hotamisligil G.S., Johnson R.S., Distel R.J., Ellis R., Papaioannou V.E., and Spiegelman B.M. Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274 (1996) 1377-1379
17. Kaushik V.K., Young M.E., Dean D.J., Kurowski T.G., Saha A.K., and Ruderman N.B. Regulation of fatty acid oxidation and glucose metabolism in rat soleus muscle: effects of AICAR. Am. J. Physiol. Endocrinol. Metab. 281 (2001) E335-E340
18. Maeda K., Uysal K.T., Makowski L., Gorgun C.Z., Atsumi G., Parker R.A., Bruning J., Hertzel A.V., Bernlohr D.A., and Hotamisligil G.S. Role of the fatty acid binding protein mal1 in obesity and insulin resistance. Diabetes 52 (2003) 300-307
19. Makowski L., Boord J.B., Maeda K., Babaev V.R., Uysal K.T., Morgan M.A., Parker R.A., Suttles J., Fazio S., Hotamisligil G.S., and Linton M.F. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat. Med. 7 (2001) 699-705
20. Matsuzawa Y., Funahashi T., and Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann. N Y Acad. Sci. 892 (1999) 146-154
21. Minokoshi Y., Kim Y.B., Peroni O.D., Fryer L.G., Muller C., Carling D., and Kahn B.B. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415 (2002) 339-343
22. Muoio D.M., Dohm G.L., Fiedorek Jr. F.T., Tapscott E.B., Coleman R.A., and Dohn G.L. Leptin directly alters lipid partitioning in skeletal muscle. Diabetes 46 (1997) 1360-1363
23. Ozcan U., Cao Q., Yilmaz E., Lee A.H., Iwakoshi N.N., Ozdelen E., Tuncman G., Gorgun C., Glimcher L.H., and Hotamisligil G.S. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306 (2004) 457-461
24. Razani B., Combs T.P., Wang X.B., Frank P.G., Park D.S., Russell R.G., Li M., Tang B., Jelicks L.A., Scherer P.E., and Lisanti M.P. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J. Biol. Chem. 277 (2002) 8635-8647
25. Saltiel A.R. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104 (2001) 517-529
26. Scheja L., Makowski L., Uysal K.T., Wiesbrock S.M., Shimshek D.R., Meyers D.S., Morgan M., Parker R.A., and Hotamisligil G.S. Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice. Diabetes 48 (1999) 1987-1994
27. Sethi J.K., and Hotamisligil G.S. The role of TNF alpha in adipocyte metabolism. Semin. Cell Dev. Biol. 10 (1999) 19-29
28. Shimano H., Shimomura I., Hammer R.E., Herz J., Goldstein J.L., Brown M.S., and Horton J.D. Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene. J. Clin. Invest. 100 (1997) 2115-2124
29. Shulman G.I. Cellular mechanisms of insulin resistance. J. Clin. Invest. 106 (2000) 171-176
30. Sjogren K., Hellberg N., Bohlooly Y.M., Savendahl L., Johansson M.S., Berglindh T., Bosaeus I., and Ohlsson C. Body fat content can be predicted in vivo in mice using a modified dual-energy X-ray absorptiometry technique. J. Nutr. 131 (2001) 2963-2966
31. Skyler J.S., and Oddo C. Diabetes trends in the USA. Diabetes Metab. Res. Rev. (2002) S21-S26
32. Soukas A., Cohen P., Socci N.D., and Friedman J.M. Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev. 14 (2000) 963-980
33. Spiegelman B.M., and Flier J.S. Obesity and the regulation of energy balance. Cell 104 (2001) 531-543
34. Tilg H., and Diehl A.M. Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med. 343 (2000) 1467-1476
35. Tong P., Khayat Z.A., Huang C., Patel N., Ueyama A., and Klip A. Insulin-induced cortical actin remodeling promotes GLUT4 insertion at muscle cell membrane ruffles. J. Clin. Invest. 108 (2001) 371-381
36. Uysal K.T., Wiesbrock S.M., Marino M.W., and Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389 (1997) 610-614
37. Uysal K.T., Scheja L., Wiesbrock S.M., Bonner-Weir S., and Hotamisligil G.S. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141 (2000) 3388-3396
38. Winder W.W., and Hardie D.G. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am. J. Physiol. 277 (1999) E1-10
39. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., Mori Y., Ide T., Murakami K., Tsuboyama-Kasaoka N., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat. Med. 7 (2001) 941-946
40. Yuan M., Konstantopoulos N., Lee J., Hansen L., Li Z.W., Karin M., and Shoelson S.E. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293 (2001) 1673-1677
41. Zimmet P., Alberti K.G., and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414 (2001) 782-787